Table of Contents
A common question from patients choosing between NMN IV and NAD+ IV therapy is whether the protocols produce equivalent results. Research and clinical evidence suggest that a 2-week course of NMN IV (300mg, twice per week) is comparable to — and in some measures superior to — 7–10 consecutive days of NAD+ IV therapy.
The Clinical Comparison #
| Protocol | Typical Course | Mechanism | Outcome Profile |
|---|---|---|---|
| NMN IV (300mg 2x/week) | 2 weeks (4 infusions) | Precursor → body converts to NAD+ intracellularly | Sustained elevation; smoother experience |
| NAD+ IV (500–1000mg/day) | 7–10 consecutive days | Direct NAD+ delivery into bloodstream | Rapid spike; faster initial impact |
Key Findings #
- NMN IV at 300mg twice per week is comparable to 500–1000mg NAD+ IV for 7–10 days in terms of overall NAD+ replenishment, according to available research
- NMN provides more sustained post-treatment levels because the body continues to synthesize NAD+ from the NMN precursor, rather than simply absorbing pre-formed NAD+ that is quickly metabolized
- NMN IV tends to cause fewer side effects (less flushing, nausea, and discomfort) compared to high-dose NAD+ infusions
- For long-term NAD+ optimization, the NMN protocol appears to offer more consistent and durable results
Which Should You Choose? #
The choice depends on your goal:
- Choose NAD+ IV if you need a rapid, high-impact intervention — for example, acute neurological recovery, post-surgery healing, or a time-constrained protocol window
- Choose NMN IV if your focus is long-term NAD+ optimization, metabolic health, and sustained cognitive and energy improvements with fewer session days and a more comfortable experience
- Consider NMN Hybrid+ (NMN + NAD+ combined) if you want both the immediate impact of NAD+ and the sustained elevation provided by NMN
Our medical team will help you determine the optimal protocol based on your biomarkers, health goals, and timeline. Book a consultation to discuss your personalized plan.
